These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9159660)

  • 1. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Guthrie R
    J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of metformin in the treatment of type 2 diabetes mellitus.
    Davidson MB; Peters AL
    Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: a new oral biguanide.
    Campbell RK; White JR; Saulie BA
    Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in noninsulin-dependent diabetes mellitus.
    Lee AJ
    Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin: a safe and effective treatment in the management of NIDDM.
    Kilo C
    Mo Med; 1997 Mar; 94(3):114-23. PubMed ID: 9071866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: an antihyperglycemic agent for treatment of type II diabetes.
    Melchior WR; Jaber LA
    Ann Pharmacother; 1996 Feb; 30(2):158-64. PubMed ID: 8835050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes.
    Johnson M; Krosnick A; Carson P; McDade AM; Laraway K
    Clin Ther; 1998; 20(4):691-8. PubMed ID: 9737829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ; Peters DH
    Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.
    Koliaki C; Doupis J
    Adv Ther; 2012 Dec; 29(12):993-1004. PubMed ID: 23184570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
    Setter SM; Iltz JL; Thams J; Campbell RK
    Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin hydrochloride: an antihyperglycemic agent.
    Klepser TB; Kelly MW
    Am J Health Syst Pharm; 1997 Apr; 54(8):893-903. PubMed ID: 9114921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic utility of biguanides in the treatment of NIDDM].
    Fujimoto S
    Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.